Cue Biopharma Inc (CUE)
1.705
+0.22
(+14.81%)
USD |
NASDAQ |
Nov 05, 16:00
1.74
+0.04
(+2.05%)
After-Hours: 18:13
Cue Biopharma Price to Book Value: 4.748 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.135 |
| November 01, 2024 | 4.232 |
| October 31, 2024 | 4.483 |
| October 30, 2024 | 4.873 |
| October 29, 2024 | 4.706 |
| October 28, 2024 | 4.956 |
| October 25, 2024 | 4.121 |
| October 24, 2024 | 4.344 |
| October 23, 2024 | 4.372 |
| October 22, 2024 | 4.455 |
| October 21, 2024 | 4.678 |
| October 18, 2024 | 3.369 |
| October 17, 2024 | 3.091 |
| October 16, 2024 | 2.980 |
| October 15, 2024 | 3.119 |
| October 14, 2024 | 3.369 |
| October 11, 2024 | 3.425 |
| October 10, 2024 | 3.704 |
| October 09, 2024 | 3.355 |
| October 08, 2024 | 3.425 |
| October 07, 2024 | 3.857 |
| October 04, 2024 | 3.230 |
| October 03, 2024 | 2.281 |
| October 02, 2024 | 2.042 |
| October 01, 2024 | 2.004 |
| Date | Value |
|---|---|
| September 30, 2024 | 2.108 |
| September 27, 2024 | 1.528 |
| September 26, 2024 | 1.022 |
| September 25, 2024 | 1.069 |
| September 24, 2024 | 1.090 |
| September 23, 2024 | 1.078 |
| September 20, 2024 | 1.179 |
| September 19, 2024 | 1.271 |
| September 18, 2024 | 1.246 |
| September 17, 2024 | 1.282 |
| September 16, 2024 | 1.268 |
| September 13, 2024 | 1.325 |
| September 12, 2024 | 1.305 |
| September 11, 2024 | 1.326 |
| September 10, 2024 | 1.280 |
| September 09, 2024 | 1.280 |
| September 06, 2024 | 1.327 |
| September 05, 2024 | 1.417 |
| September 04, 2024 | 1.487 |
| September 03, 2024 | 1.480 |
| August 30, 2024 | 1.625 |
| August 29, 2024 | 1.622 |
| August 28, 2024 | 1.575 |
| August 27, 2024 | 1.640 |
| August 26, 2024 | 1.644 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.022
Minimum
Sep 26 2024
19.33
Maximum
Jun 02 2020
4.630
Average
3.463
Median
Jan 03 2024
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.326 |
| Arbutus Biopharma Corp | 6.097 |
| GlycoMimetics Inc | 1.253 |
| FibroGen Inc | -- |
| Cidara Therapeutics Inc | 0.7219 |
Price to Book Value Related Metrics
| PS Ratio | 9.927 |
| Price | 1.705 |
| Earnings Yield | -57.48% |
| Market Cap | 102.65M |